返回
S
Sandip Basu
bhabha atomic research center
47H指数
618论文数
8.4K被引数
收录论文 171
发表时间
Evaluation of [225Ac]Ac-PSMA-617 vis-a-vis Rechallenge [177Lu]Lu-PSMA-617 PRLT Versus Cabazitaxel or Oral Metronomic Chemotherapy in mCRPC: An Observational Analysis of Outcome and Toxicity Profiles in a Real-World Clinical Scenario评估[225Ac]Ac-PSMA-617与重复[177Lu]Lu-PSMA-617 PRLT相比卡巴他赛或口服规律化疗在mCRPC中的疗效和毒性特征:真实世界临床场景下的观察性分析
Prostate
IF2.5
Correction to: Inter- and intra-quartile comparison of multi-tracer PET/CT and liquid biopsy molecular markers in cancer: a futuristic perspective on evolving a “stepped care” model for individualized precision theranostics through AI/ML更正:多示踪剂PET/CT与液体活检分子标志物的组间和组内四分位数比较:通过人工智能/机器学习发展“分层护理”模型以实现个体化精准诊疗的未来展望
[ 18 F]F FDG PET/CT and [ 68 Ga]Ga-FAPI-4 PET/CT Imaging Following EGFR Targeted Erlotinib Treatment Toward Accurate Disease Status Evaluation in Metastatic or Advanced Head and Neck squamous Cell Carcinoma (HNSCC): A Complementary Role?[18F]F-FDG PET/CT和[68Ga]Ga-FAPI-4 PET/CT成像在转移性或晚期头颈鳞状细胞癌(HNSCC)中接受EGFR靶向厄洛替尼治疗后评估疾病状态的互补作用?
Small Cell Transformation of Metachronous ALK plus ve Lung and Prostatic Adenocarcinoma following Initial Response to Ceritinib and Androgen Deprivation Therapies and Metastases to Two Different Organs: Guidance through FDG-PET/CT and 68 Ga-PSMA-11 PET-CT and Biopsy-Immunohistochemistry Correlation异时性ALK阳性肺癌和前列腺腺癌在初始接受塞瑞替尼和雄激素剥夺疗法产生应答后发生小细胞癌转化,并出现向两个不同器官的转移:通过FDG-PET/CT、⁶⁸Ga-PSMA-11 PET-CT及活检-免疫组化相关性进行指导。
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium − 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)PReCedeNT试验:一项III期随机对照试验,比较镥-177 DOTATATE肽受体放射性核素治疗(PRRT)联合化疗与PRRT单药治疗在FDG摄取阳性、分化良好的胃肠胰神经内分泌肿瘤(GEP-NETs)中的疗效。
BMC Cancer
IF3.4

